Cempra to Report First Quarter 2016 Financial Results
April 25, 2016 07:30 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., April 25, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Melinta Therapeutics Appoints Dr. Eugene Sun as Chief Executive Officer
April 19, 2016 08:00 ET
|
Melinta Therapeutics
NEW HAVEN, Conn, April 19, 2016 (GLOBE NEWSWIRE) -- The Board of Directors of Melinta Therapeutics today announced that Eugene Sun, M.D., has been appointed Melinta’s Chief Executive Officer and...
Tetraphase Pharmaceuticals to Present at Roth Conference 2016
March 10, 2016 09:10 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., March 10, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
Melinta Therapeutics Appoints John Temperato President and Chief Operating Officer
February 23, 2016 08:00 ET
|
Melinta Therapeutics
New Haven, CT, Feb. 23, 2016 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced that John Temperato has joined Melinta as President and Chief Operating Officer. Prior to joining Melinta,...
Melinta Therapeutics Initiates Phase 3 Study of Baxdela in Hospital-Treated Community-Acquired Bacterial Pneumonia
January 06, 2016 08:00 ET
|
Melinta Therapeutics
New Haven, CT, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat bacterial infections, announced the initiation of an...
Melinta Therapeutics to Present at 34th Annual J.P. Morgan Healthcare Conference
January 05, 2016 08:00 ET
|
Melinta Therapeutics
New Haven, CT, Jan. 05, 2016 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced that Dr. Eugene Sun, the Company’s interim Chief Executive Officer, will be providing a corporate update at...
Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award
November 30, 2015 10:00 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that it was named "Company of the Year" by BioAlberta during the Association's 16th Annual General...
District of Columbia Hospital Association Chooses OpGen to Create Citywide Effort to Track Multidrug-Resistant Bacteria
November 18, 2015 08:30 ET
|
OpGen, Inc.
GAITHERSBURG, Md. and WASHINGTON, Nov. 18, 2015 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) and the District of Columbia Hospital Association (DCHA) today announced that Washington DC’s public...
Survey: Americans Prioritize Affordability and Nutrition Over Non-GMO, Organic and Antibiotic-Free Foods
October 14, 2015 13:53 ET
|
The Chicago Council on Global Affairs
CHICAGO, Oct. 14, 2015 (GLOBE NEWSWIRE) -- Despite high-profile debates in the media about GMOs, organics and antibiotic-free food, the majority of Americans care most about the cost and nutrition of...
Data Show “Super Bug” Surveillance System Based on OpGen’s Acuitas(R) Resistome Test Can Identify Potential Outbreaks in Hospitals and Improve Infection Control
October 12, 2015 08:30 ET
|
OpGen, Inc.
GAITHERSBURG, Md., Oct. 12, 2015 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), an early-stage commercial molecular testing and bioinformatics company, today announced that new data from a...